Is Nirmatrelvir/Ritonavir combination included in medical insurance?

Nirmatrelvir/Ritonavir combination Paxlovid (Nirmatrelvir/Ritonavir) is an oral combination drug used to treat coronavirus disease 2019. It consists of the protease inhibitor nematvir, which targets the major protease of severe acute respiratory syndrome coronavirus type 2, and the cytochrome P450 (CYP) 3A inhibitor ritonavir.

Nematrevir/Ritonavir tablet combination is an antiviral drug that can reduce the ability of the new coronavirus to reproduce in the body. The active substance nematvir blocks the activity of an enzyme required for the virus to multiply. Low doses of the drug ritonavir can slow down the breakdown of nematvir, allowing it to stay in the body longer to a level that affects viral proliferation. Together, these active substances help the body overcome viral infections and prevent the disease from getting worse.

NematrevirThe combination of nematvir/ritonavir tablets has been launched in China. Due to its short time on the market, it has not been included in the medical insurance. The domestic price has not yet been determined. The original drug of nematvir/ritonavir tablet combination marketed overseas, the specification is nematvir 150mg + ritonavir 100mg)*30 tablets per box, the price may be around 2,000 yuan (the price may fluctuate due to the exchange rate), India The price of each box of the generic Nematvir/Ritonavir tablet combination produced by the pharmaceutical factory may be around RMB 1,000 (the price may fluctuate due to the exchange rate). The ingredients of the two drugs are basically the same. For more drug information and specific prices, please consult Yaode Medical Consultant.